Adam J. Fein @DrugChannels
Expert insights from Dr. Adam J. Fein on pharmaceutical economics and the drug distribution system. Contact me at [email protected] linktr.ee/DrugChannels Philadelphia, PA Joined March 2009-
Tweets8K
-
Followers18K
-
Following4
-
Likes3K
Please say hello to Bar Stern, the newest and most bearded member of the DCI team! Bar joins us as a Senior Manager. Meet him at #Asembia24 and connect with him here: linkedin.com/in/bar-stern/ P.S. Contact me if you are interested in joining DCI!
From @CoverMyMeds: Breaking Down Barriers: Helping Patients Get Therapies Quickly Sign up for free daily recaps from #Asembia24 @asembiarx: drugch.nl/3xGQQBU Read the article: drugch.nl/3WgwsSx #sponsored
#Biosimilar price war update: @Evernorth (@ExpressScripts) $CI launches its own private label Humira w/list "about 85% lower." Twist: Available via Quallent Pharmaceuticals, a Cayman Island-based (!) subsidiary 👀 drugch.nl/3wbRhnv
Notable new discloure: @Walgreens $WBA is a much bigger specialty #pharmacy player than most of us had known. $24B in total specialty #prescription revenue (central-fill+community SPs+retail) = 10% of market Viable alternative to #PBM-aligned pharmacies? drugch.nl/4b9ipm6
Our latest: Independents Outshine #PBMs in Manufacturers’ Exclusive Specialty #Pharmacy Networks DCI's exclusive analysis of manufacturer-designated dispensing networks. drugch.nl/3Ug0lzS
Unfun fact: During the pandemic, #healthcare spending became more concentrated Top 1% of population = 24% of spending Top 5% of population = 51% of spending @AHRQNews ==> drugch.nl/445c9t1
Notable #wholesale contract switch: OptumRx $UNH switches its $30B+ mail and specialty #pharmacy #PBM drug purchasing from @cardinalhealth $CAH to @McKesson $MCK drugch.nl/4aKdOGW
Visit Booth #1801 at #Asembia24 for “Ask Me Anything With Adam” (#AMAWA) ==> Monday, 4/29, 4:30 p.m. @asembiarx - Drug Channels Wheel O’ Fun! - Chat w/Paula & Bar! - Drug Channels Leadership Forum! - Snacks, treats, espresso! Details: drugch.nl/asembia24
Medicare-Negotiated #Drugs May Not Get Favorable Coverage In Part D: Will CMS Intervene? Some highlights on #PBM formulary strategies from my recent #IRA webinar @PharmaPinkSheet drugch.nl/3TWOcj4
Great resource for the weekend from @46brooklyndata: A glossary of drug pricing terms! One my favorite terms is included 😉 drugch.nl/3POHtX1
Here's a fun summary of my keynote to the inaugural @ONCARE Alliance meeting. Great group! Very much appreciated the opportunity.
From @GoodRx: How GoodRx is Evolving Its Reimbursement Approaches to Help Pharmacies and Consumers Learn more about GoodRx's pharmacy partnerships: drugch.nl/43VLcYM Read the article: drugch.nl/3Qdk6qr #sponsored
ICYMI, I highly recommend reading William Sarraille's open letter to @SecBecerra. He outlines 3 reasons why the Secretary's testimony refelected a "heartless, arrogant disregard of the patient and an embarrassing level of misinformation." drugch.nl/3Und3Ox…
Wow. Secretary Becerra's @SecBecerra testimony was painful to watch, because he was deeply misinformed about the facts and seemed to directly misrepresent @HHSGov actions on #accumulators. Shameful. Kudos to @RepBuddyCarter Watch for yourself: youtu.be/Hbd7KKZxbmE?si…
Another #340b myth busted: Medicare & its beneficiaries paid #hospitals $3.9 billion (+48%) more than #340b acq. cost for 189 #PartB #drugs. #BecauseOf340B, taxpayers & seniors *directly* funded #340b profit margins. @medicarepayment ==> drugch.nl/4cXf6A8
Seriously?!? #BecauseOf340B, @BrighamWomens in Boston (!) is a "rural" referral center for #340B cash—yet 97% of its patients live in urban areas! Another large, non-profit #hospital abusing #340B & risking program for true safety-net providers ==>drugch.nl/3J8ChJY
The Top 15 Specialty #Pharmacies of 2023: Market Shares and Revenues at the Biggest #PBMs, Health Plans, and Independents DCI's latest market analysis of this booming market sector @CVSHealth $CVS @ExpressScripts $CI @OptumRx $UNH drugch.nl/3UjmPBf
From @USGAO: Useful overview of state laws that regulate #PBMs (AR, CA, LA, ME, NY) GAO outlines (but doesn't directly) evaluate stakeholders' differing positions ==> drugch.nl/3U0M1Lf
Wow! Big jump in @Sandoz_Global Hyrimoz #biosimilar prescriptions 👇 Credit @CVSHealth $CVS, which dropped #Humira from its major commercial formularies on 4/1 (See drugch.nl/49EbT5q) Analysis via Elizabeth Anderson @EvercoreISI (Sorry, full report not public.)
Adam Feuerstein ✡�.. @adamfeuerstein
114K Followers 750 Following Reporter @statnews. The Harry Kane of biotech. Dog ❤️er. Polk Award winner. #COYS. Said one analyst: The likes of Adam Feuerstein attack viciously.
Nikhil Krishnan @nikillinit
54K Followers 1K Following Thinkboi the only funny + non-jargon healthcare newsletter: https://t.co/61zgESgkhw learn healthcare quickly with crash courses: https://t.co/C6cWc5YHK7
Antonio Ciaccia @A_Ciaccia
7K Followers 3K Following Advocate for drug price transparency, competitive healthcare markets, & patient-centered care @46brooklyndata @3AxisAdvisors. Dad to Franco, Marco, Vera, Enzo.
Peter Kolchinsky @PeterKolchinsky
66K Followers 181 Following Managing Partner, RA Capital Management. We build & invest in biotech companies. Scientist. Author, The Great American Drug Deal. https://t.co/ARVLrrTQU4
Bertrand Delsuc @BertrandBio
16K Followers 253 Following Views=mine only, RT-like=/=endorse, no advice. 16y in Tech (chip design) & a bit of Bio :)
Bruce Booth @LifeSciVC
50K Followers 732 Following Early stage biotech VC. Recovering scientist. Opinions expressed are solely my own and do not express the views or opinions of Atlas Venture.
Matthew Herper @matthewherper
111K Followers 3K Following Writing and events at STAT. This is biology's century; Every data point has a face. ‘21 Polk Award. Mastodon: @[email protected]
Blake Madden 🏥 @B_Madden4
14K Followers 1K Following I break down the $4.5T business of healthcare after working on the inside. Essays on strategy, M&A, finance, health tech, & more. Texas ex, golfer, father
Jing Liang 🇺🇦 @AppleHelix
8K Followers 4K Following Entrepreneur. Drug hunter. Novice biotech scripophile. Anti-ideologues. Proudly blocked by @VPrasadMDMPH. https://t.co/zMzJBoov2V
Andrew Pannu @andrewpannu
10K Followers 274 Following daily dose of biotech & healthcare commentary • founder • building software for the bioeconomy (we’re hiring software engineers!)
NCPA @Commpharmacy
24K Followers 3K Following NCPA represents over 19,400 pharmacies that employ 230,000+ folks nationwide. Community pharmacists are among America’s most accessible health care providers.
Ted Okon @TedOkonCOA
6K Followers 603 Following Commenting on cancer, health care reform & politics — a lethal combination. Advocating for a better America.
Andy Biotech @AndyBiotech
78K Followers 746 Following #Biotech Investor | Recovering Scientist | May have L/S position in names mentioned | Opinions are strictly my own and not intended as investment advice
REDBEARD1969 @redlgb1969
2K Followers 3K Following Fighting for pharmacy and pharmacists ⚜️ just another Jaded Pharmacist
Stacie Dusetzina @DusetzinaS
12K Followers 2K Following Health services researcher at Vanderbilt Health Policy. Avid coffee drinker, investigator of drug policies & prices. RT not an endorsement. Opinions are mine.
Peter B. Bach, MD @peterbachmd
14K Followers 1K Following Chief Med Officer @DELFIdiagnostic. Pulmonary & ICU doc. Tweets about health policy and grammar. Viewpoints my own.
Zach Brennan @ZacharyBrennan
10K Followers 1K Following Senior Editor, Endpoints News - covering the FDA, Capitol Hill, regulatory policy, and all things biotech/pharma - reach me at [email protected]
Matt Thompson @mwthom90
112 Followers 570 Following Mizzou Alum | Political Staffer | Opinions are my own
Yafees Sarwar @yafees
523 Followers 3K Following Head of Marketing @ CYTENA | Founder @ Biosciencing
LemuelOlien @LemuelOlie54812
17 Followers 688 Following
elmo @selenagomeows
3 Followers 50 Following
CMT @caylortaylor
137 Followers 258 Following
Alex Koch @AlexBK7777
67 Followers 149 Following recovering suit wearer. the Packers are America's team
Will o’ the Wisp Tr.. @StansfieldTrish
572 Followers 4K Following InsatiablePhilomath📚BLM✊🏼Laughter🤣UnabashedLiberal🩰Singer🎤SAG/AFTRA/AEA🎭SciNerd🧬PragmaticIdealist🫶🏻Compassion🎨Ally🏳️🌈🏳️⚧️MemeThief🫂Empath🥊Facts
ZenobiaGunther @ff3wd32opYpS32
30 Followers 952 Following
Bill Versosky @b3fv01
60 Followers 587 Following
Alexander Ward @Ajward44
0 Followers 16 Following
azcats8715 @azcats8715
74 Followers 414 Following
Charlie Katebi @CharlieKatebi
173 Followers 223 Following Deputy Director, Center for a Healthy America at @A1Policy
Mitch Guber @MitchGuber
171 Followers 360 Following
Þorbjörn Atli @sveinssont
123 Followers 219 Following
TRỊNH ĐỨC DUY @DUCDUY_PM_TRINH
181 Followers 3K Following
bri @sirshibb
172 Followers 809 Following
Andy Johnson @AndyJoh69366203
73 Followers 316 Following
Jeffrey Poirier, MBA,.. @pcpharmacist
139 Followers 213 Following Director of the PharmacyChecker Verification Program. Follow my work @pharmacychecker | Registered NH Pharmacist | Avid outdoorsman & restorer of old cars.
Danielle Geiger @GeigerDgeiger
0 Followers 3 Following
Christina Roque @rxroque
4 Followers 255 Following
Carl Fawkes @carlfawkes
1K Followers 316 Following CFO working with and investing in healthcare startups/scaleups. Angel investor. Long distance runner. Cricket lover. #ncfc.
McDythea @DytheaMc63631
25 Followers 288 Following In the dull and boring world, there is also occasional luck. No cross, no crown.
Santiago Llano C. @sllanocavina
234 Followers 291 Following
Jeremy Cates @GenZPharmD
8 Followers 46 Following
GLP-1 News @GLP1_News
261 Followers 90 Following Stay in the know with your #1 source for all things GLP-1. #Mounjaro #Ozempic #Rybelsus #Saxenda #Trulicity #Victoza #Wegovy #Zepbound #GLP1 #releasethevials
Kaustuv Bhattacharya @kaustuvbh
199 Followers 1K Following Health Economics and Outcomes Researcher, Wodehouse fan, and football enthusiast
Lisa @Lisa82446588
869 Followers 2K Following I'm 58, Living with Leukemia,💔Trigeminal Neuralgia, Osteoporosis, etc., and I HATE IT‼️😢🙏🏻🛐🌻 #MAGA #KAG #AmericaFirst #Vets #2A #MAGA2024 #BuildtheWall
Eric Trierweiler @ETrierweiler
48 Followers 276 Following
Andrew Frank @Justbeingfrank3
113 Followers 321 Following
David Eggert @DavidEggert00
29K Followers 4K Following Politics/policy reporter for @CrainsDetroit & @CrainsGR | Formerly @AP & various newspapers | Husband/dad, @NorthwesternU grad | [email protected]
Gabriela Hornackova @GHornackova
48 Followers 562 Following Founder of GH Legal & Tech Innovations | Tech and AI Entrepreneur | Advancing AI in Legal Systems | Intersection between Technology, AI and the Law
Pharmacy Uprising @pharmcyuprising
8 Followers 56 Following Exposing Pharmacy Be edit Managers for what they really are and advocating for PBM reform.
Alex Gorman @AGorman32
74 Followers 108 Following
peony @pe0nygirl
45 Followers 766 Following
Miles Morrison @MilesMediaWorks
5 Followers 29 Following Miles Media Works specializes in creating a web presence for small businesses. With the ability to create an online storefront for your business.
Jarod Facundo @dorajfacundo
2K Followers 2K Following Health care antitrust reporter @Capitol_Forum | 📧 jfacundo(@)thecapitolforum(.)com or DM for Signal | My feed. Nobody else’s.
Ben Brown @BenBrownMass
144 Followers 640 Following
Senior PharmAssist @SrPharmAssist
300 Followers 262 Following Senior PharmAssist helps seniors in Durham obtain and better manage needed medications & provides tailored community referrals & Medicare insurance counseling.
Brandon Holbrook @BHolbie42
59 Followers 398 Following 2010 University of Cincinnati James L Winkle College of Pharmacy grad. Proud owner of Holbrook's Hometown Pharmacy, husband and father of three.
BOSS @SEIOB
250 Followers 519 Following @NFL @SPURS @KUHoops @AtlantisBahamas #KC/#MIA/#NOLA/#H_TOWN/#SA
Antonio Ciaccia @A_Ciaccia
7K Followers 3K Following Advocate for drug price transparency, competitive healthcare markets, & patient-centered care @46brooklyndata @3AxisAdvisors. Dad to Franco, Marco, Vera, Enzo.
Peter Kolchinsky @PeterKolchinsky
66K Followers 181 Following Managing Partner, RA Capital Management. We build & invest in biotech companies. Scientist. Author, The Great American Drug Deal. https://t.co/ARVLrrTQU4
Audrey (Fein) Plaut @AudreyPlaut
412 Followers 158 Following Strategy Consultant @Accenture dedicated to designing world class patient experiences #pharma / all views my own
Scott Gottlieb, MD @ScottGottliebMD
575K Followers 2K Following Senior Fellow @AEI. Partner @NEA. Contributor @CNBC. 23rd @US_FDA Commissioner. Boards: @Pfizer @Illumina @AetionInc @TempusAI @IncResilience @ComancheBio Xaira
The #340B Drug Pricing Program is meant to help patients access affordable medicines, but instead only drives up costs for taxpayers. 340B should benefit patients, not profits.
Another #340b myth busted: Medicare & its beneficiaries paid #hospitals $3.9 billion (+48%) more than #340b acq. cost for 189 #PartB #drugs. #BecauseOf340B, taxpayers & seniors *directly* funded #340b profit margins. @medicarepayment ==> drugch.nl/4cXf6A8
Just 35% of 340B hospitals and 23% of 340B contract pharmacies are located in the medically-underserved areas they are intended to serve. Hospitals are taking advantage of a program meant to help vulnerable patients. #Fix340B
Seriously?!? #BecauseOf340B, @BrighamWomens in Boston (!) is a "rural" referral center for #340B cash—yet 97% of its patients live in urban areas! Another large, non-profit #hospital abusing #340B & risking program for true safety-net providers ==>drugch.nl/3J8ChJY
Independents Outshine PBMs in Manufacturers’ Exclusive Specialty Pharmacy Networks - from @DrugChannels ow.ly/ki5p50Ro3Cz
Expand your drug pricing vocabulary and wow your dinner guests 💊
Great resource for the weekend from @46brooklyndata: A glossary of drug pricing terms! One my favorite terms is included 😉 drugch.nl/3POHtX1
Drive-by analysis of accelerated approval is intellectual malpractice biocentury.com/article/652132…
Great @steveusdin1 commentary: "The point of accelerated approval is not perfection; it’s to allow risk-taking when there’s evidence that a therapy is reasonably likely to benefit patients who are suffering from a serious condition."
Drive-by analysis of accelerated approval is intellectual malpractice biocentury.com/article/652132…
Does this answer your question, @SecBecerra?
It’s consistently embarrassing to see Xavier Becerra speak when he obviously has no idea how any of the programs he’s supposed to run actually function.
Wow. Secretary Becerra's @SecBecerra testimony was painful to watch, because he was deeply misinformed about the facts and seemed to directly misrepresent @HHSGov actions on #accumulators. Shameful. Kudos to @RepBuddyCarter Watch for yourself: youtu.be/Hbd7KKZxbmE?si…
"The Top 15 Specialty Pharmacies of 2023: Market Shares and Revenues at the Biggest PBMs, Health Plans, and Independents drugchannels.net/2024/04/the-to…" via @DrugChannels. The highlighted players have some connection to the Louisville area.
"The Top 15 Specialty Pharmacies of 2023: Market Shares and Revenues at the Biggest PBMs, Health Plans, and Independents go.shr.lc/3vS91Eo" via @DrugChannels.
Drug Channels Institute’s (DCI’s) latest analysis finds that participants in the specialty pharmacy market continue to get more diverse—although revenues remain highly concentrated - from @DrugChannels ow.ly/x7Ir50Rh8SN
"There’s a certain irony in 'inflation reduction' legislation leading to massive price increases." @brianreid costcurvenews.com/2024/04/11/wor…
MedPAC wants to know why the prices yielded by PBMs at the pharmacy counter are set in a casino-like fashion. Maybe because it is a casino. medpagetoday.com/publichealthpo… @medpagetoday @medicarepayment @costplusdrugs @mcuban @alexosh
If you are a self-insured company, THE FASTEST WAY TO CREATE CASH is to get all employees and covered persons to switch from Humira to Yusimry. The first costs you 80k per year. Yusimry from costplusdrugs.com/medications/yu… Cost 7,200 per year. That's $72,800 PER EMPLOYEE PER YEAR. You…
Essential report from @DrugChannels highlighting the latest market share distribution and trends in the ever-growing and evolving pharmacy benefits management industry drugchannels.net/2024/04/the-to…
Yet another reality check about # PBMs
The Top Pharmacy Benefit Managers of 2023: Market Share and Trends for the Biggest Companies—And What’s Ahead DCI's latest #PBM data, along with a preview of the next few years. @CVSHealth $CVS @ExpressScripts $CI @OptumRx $UNH drugch.nl/4au5JWU drugch.nl/4au5JWU
79% market share for top three PBMs combined... keeping their grip on decisions about how much you pay for prescription drugs
The Top Pharmacy Benefit Managers of 2023: Market Share and Trends for the Biggest Companies—And What’s Ahead DCI's latest #PBM data, along with a preview of the next few years. @CVSHealth $CVS @ExpressScripts $CI @OptumRx $UNH drugch.nl/4au5JWU drugch.nl/4au5JWU
Hospitals are becoming major players in specialty pharmacy, using exclusive networks & physician control to steer patients to their own in-house pharmacies. squeezing out competition, could impact patient access to medications. #healthcare #pharmacy #340B #specialtydrugs
Vertical Integration Lessons: The Economics and Strategies of Hospital-Owned Specialty #Pharmacies (rerun) Are manufacturers and payers ready for hospital-owned specialty pharmacies' growing power and market tactics? ==> drugch.nl/3TIuQhG drugch.nl/3TIuQhG
According to @DrugChannels, "For 2024, the three largest pharmacy benefit managers (PBMs)—Caremark (CVS Health), Express Scripts (Cigna), and OptumRx (United Health)—have again each excluded 600 or more drugs from their standard formularies." Read more: drugchannels.net/2024/04/the-bi…
Very good read.
What @cvspharmacy’s New Cost-Plus Reimbursement Approach Means for #PBMs, #Pharmacies, Plan Sponsors, and Prescription Prices (rerun) @CVSHealth $CVS ==> drugch.nl/43DLYK1 drugch.nl/43DLYK1
Trends for United States
You might like
